Osteoporosis how is it diagnosed

Note: we are unable to answer specific questions or offer individual medical advice or opinions. Please contact your physician with specific medical questions or for a referral to a radiologist or other physician. To locate a medical imaging or radiation oncology provider in your community, you can search the ACR-accredited facilities database. This website does not provide cost information.

The costs for specific medical imaging tests, treatments and procedures may vary by geographic region. Web page review process: This Web page is reviewed regularly by a physician with expertise in the medical area presented and is further reviewed by committees from the Radiological Society of North America RSNA and the American College of Radiology ACR , comprising physicians with expertise in several radiologic areas.

Outside links: For the convenience of our users, RadiologyInfo. Toggle navigation. What is osteoporosis? How is osteoporosis diagnosed and evaluated? How might osteoporosis be treated? Osteoporosis can be present for years without any noticeable symptoms, but signs can include: Severe back pain Loss of height over time A stooped posture Bone fractures from minor injury. The following procedures can be performed to determine bone fractures due to osteoporosis: Bone x-ray : Bone x-ray produces images of bones within the body, including the hand, wrist, arm, elbow, shoulder, foot, ankle, leg shin , knee, thigh, hip, pelvis or spine.

Read more on myDr website. Bone health is an important part of general health. Bones are flexible yet strong for movement and protect vital organs. When the structure of bone is compromised and becomes weaker and less dense the bone has an increased risk of breaking.

This is osteoporosis. Read more on Healthy Bones Australia website. This decreased density means the bones are weaker, thinner and more fragile, which makes them more susceptible to breakage. Read more on Ausmed Education website. Osteoporosis is a condition characterised by weakened bones that fracture easily. After menopause many women are at risk of developing osteoporosis.

The female sex hormone oestrogen plays an important role in maintaining bone strength. After menopause oestrogen levels drop and this may result in increased bone loss.

The average woman loses up to 10 per cent of. Read more on Australasian Menopause Society website. The menopause is sometimes called 'the change of life' as it marks the end of a woman's reproductive life. Read more on Australian Prescriber website. The symptoms of coeliac disease vary markedly from person to person. What is the gold standard for diagnosing coeliac disease? Up to 1 in 5 sports supplements contain banned substances. Find out what to look for and how to manage patients with adverse effects.

It usually occurs between the ages of 45 and 55 with an average age of A person is considered to be postmenopausal after 12 consecutive months without experiencing a period. AMS provides information for doctors and other health practitioners in supporting women through midlife health and the menopause.

Our Information Sheets have been organised into the following management categories for ease of reference. Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.

There is a total of 5 error s on this form, details are below. This can occur after an invasive dental procedure, such as removing a tooth. Compared with bisphosphonates, denosumab Prolia, Xgeva produces similar or better bone density results and reduces the chance of all types of fractures.

Denosumab is delivered via a shot under the skin every six months. Similar to bisphosphonates, denosumab has the same rare complication of causing breaks or cracks in the middle of the thighbone and osteonecrosis of the jaw. If you take denosumab, you might need to continue to do so indefinitely. Recent research indicates there could be a high risk of spinal column fractures after stopping the drug.

Estrogen, especially when started soon after menopause, can help maintain bone density. However, estrogen therapy can increase the risk of breast cancer and blood clots, which can cause strokes. Therefore, estrogen is typically used for bone health in younger women or in women whose menopausal symptoms also require treatment. Raloxifene Evista mimics estrogen's beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen. Taking this drug can reduce the risk of some types of breast cancer.

Hot flashes are a possible side effect. Raloxifene also may increase your risk of blood clots. In men, osteoporosis might be linked with a gradual age-related decline in testosterone levels. Testosterone replacement therapy can help improve symptoms of low testosterone, but osteoporosis medications have been better studied in men to treat osteoporosis and thus are recommended alone or in addition to testosterone.

If you have severe osteoporosis or if the more common treatments for osteoporosis don't work well enough, your doctor might suggest trying:. Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center.

J Womens Health Larchmt. Ebeling PR. Clinical practice. Osteoporosis in men. Search for hidden secondary causes in postmenopausal women with osteoporosis. Management of osteoporosis in postmenopausal women: position statement of the North American Menopause Society. Geneva, Switzerland; Accessed September 6, Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review.

Physical therapy approaches to reduce fall and fracture risk among older adults. Nat Rev Endocrinol. Moyer VA; U. Prevention of falls in community-dwelling older adults: U. Too fit to fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture. Osteoporos Int. American Geriatrics Society. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev. The effects of smoking on bone metabolism. Alcohol and bone: review of dose effects and mechanisms.

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

Drugs for postmenopausal osteoporosis. Med Lett Drugs Ther. First Databank, Inc. AnalySource Monthly. Accessed September 5, Diagnosis and treatment of osteoporosis. Am Fam Physician. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int. Alendronate for the treatment of osteoporosis in men. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Arthritis Rheum. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Fracture risk and zoledronic acid therapy in men with osteoporosis. Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws [published correction appears in Ann Intern Med. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med. Silverman SL, Azria M. The analgesic role of calcitonin following osteoporotic fracture. Salmon calcitonin use and associated cancer risk. Ann Pharmacother. One year of alendronate after one year of parathyroid hormone 1—84 for osteoporosis.

Denosumab for prevention of fractures in postmenopausal women with osteoporosis [published correction appears in N Engl J Med. Effects of denosumab on fracture and bone mineral density by level of kidney function. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

Lewiecki EM. Bone density monitoring to monitor osteoporosis therapy in clinical practice. This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.

Contact afpserv aafp. Want to use this article elsewhere? Get Permissions. Read the Issue. Sign Up Now. Aug 15, Issue. Diagnosis and Management of Osteoporosis.

Author disclosure: No relevant financial affiliations. B 5 Women younger than 65 years should be screened for osteoporosis if the estimated year fracture risk equals or exceeds that of a year-old white woman with no risk factors. C 5 A fall risk assessment should be performed and a multicomponent exercise program and smoking cessation should be recommended to decrease fracture risk in individuals 65 years and older with osteoporosis or a history of vertebral fracture.

C 17 , 20 , 22 Bisphosphonates should be used as first-line pharmacologic treatment for osteoporosis. A 16 , 26 In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide Forteo and denosumab Prolia are effective alternative medications to prevent osteoporotic fractures. Enlarge Print Table 1. Impact of Osteoporosis Impact Statistics Disability pain, disability, complications 10 million Americans 50 years and older have osteoporosis of the hip 1.

Table 1. Enlarge Print Table 2. Table 2.